President Trump recently announced he is extending social distancing guidelines to April 30th. He initially hoped to lift them by Easter. This is far from the first time he has changed his mind on how to best handle the coronavirus pandemic. Although frustrating, the President’s indecisiveness is understandable. The United States recently surpassed China...
Read More »
In 2001, twenty-one-year-old Abigail Burroughs was dying of cancer. After all conventional treatment methods failed to improve her condition, Abigail’s oncologist pleaded with the Food and Drug Administration to allow her to try Erbitux. At the time, Erbitux had not fully passed the FDA’s drug approval process. Abigail was denied access and lost her...
Read More »
“It is naïve to think that public pressure has no potential to influence a judge’s opinion,” says Ronald L. Trowbridge.
According to a recent study by the Pacific Legal Foundation, 2,094 out of the 2,952 regulations issued from 2001 until 2017 by the Department of Health and Human Services were unconstitutional.
With 42 million US citizens suffering from a terminal illness or knowing someone with one, it’s a fight that affects us all.
Ms. Joy Silver’s criticisms of right-to-try laws are ill-conceived.
When treatments are unavailable, and prognoses are fatal, the best chance to prolong life is to consider all remaining options.
Right-to-try will never reach its potential without deregulation.
Right-to-try, MDMA, and Epidolex provide examples of the power of public opinion to change the scope of government.
FDA regulation holds part of the blame for high drug prices.
